These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

152 related items for PubMed ID: 18334965

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Amino-Nogo inhibits optic nerve regeneration and functional recovery via the integrin αv signaling pathway in rats.
    Huo Y, Yin XL, Ji SX, Zou H, Lang M, Zheng Z, Cai XF, Liu W, Chen CL, Zhou YG, Yuan RD, Ye J.
    Cell Physiol Biochem; 2015; 35(2):616-26. PubMed ID: 25612921
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Co-expression of c-Jun and ATF-2 characterizes the surviving retinal ganglion cells which maintain axonal connections after partial optic nerve injury.
    Kreutz MR, Bien A, Vorwerk CK, Böckers TM, Seidenbecher CI, Tischmeyer W, Sabel BA.
    Brain Res Mol Brain Res; 1999 Jun 08; 69(2):232-41. PubMed ID: 10366744
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Cytokines and neurotrophic factors fail to affect Nogo-A mRNA expression in differentiated human neurones: implications for inflammation-related axonal regeneration in the central nervous system.
    Satoh JI, Kuroda Y.
    Neuropathol Appl Neurobiol; 2002 Apr 08; 28(2):95-106. PubMed ID: 11972796
    [Abstract] [Full Text] [Related]

  • 29. Sema3A inhibits axonal regeneration of retinal ganglion cells via ROCK2.
    Zhang J, Liu W, Zhang X, Lin S, Yan J, Ye J.
    Brain Res; 2020 Jan 15; 1727():146555. PubMed ID: 31733191
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. The Nogo receptor, its ligands and axonal regeneration in the spinal cord; a review.
    Hunt D, Coffin RS, Anderson PN.
    J Neurocytol; 2002 Feb 15; 31(2):93-120. PubMed ID: 12815233
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Synergistic effect of Nogo-neutralizing antibody IN-1 and ciliary neurotrophic factor on axonal regeneration in adult rodent visual systems.
    Cui Q, Cho KS, So KF, Yip HK.
    J Neurotrauma; 2004 May 15; 21(5):617-25. PubMed ID: 15165369
    [Abstract] [Full Text] [Related]

  • 40. Tenascin-R inhibits regrowth of optic fibers in vitro and persists in the optic nerve of mice after injury.
    Becker T, Anliker B, Becker CG, Taylor J, Schachner M, Meyer RL, Bartsch U.
    Glia; 2000 Feb 15; 29(4):330-46. PubMed ID: 10652443
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.